Freeline Therapeutics Holdings Plc Adss (FRLN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2022 | 12-2021 | 12-2020 | 12-2019 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -88,972 | -140,391 | -96,322 | -53,909 | N/A |
| Depreciation Amortization | 1,741 | 2,390 | 1,913 | 1,540 | N/A |
| Income taxes - deferred | -156 | -171 | -158 | N/A | N/A |
| Accounts receivable | N/A | 98 | -91 | N/A | N/A |
| Other Working Capital | 8,252 | 19,744 | -6,678 | -1,412 | N/A |
| Other Operating Activity | 911 | 10,773 | 6,371 | 1,459 | 0 |
| Operating Cash Flow | $-78,224 | $-107,557 | $-94,965 | $-52,322 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -7,014 | -4,274 | -2,387 | -2,977 | N/A |
| Purchase Sale Intangibles | N/A | N/A | -1 | -45 | N/A |
| Other Investing Activity | 0 | 0 | -1 | -45 | 0 |
| Investing Cash Flow | $-7,014 | $-4,274 | $-2,388 | $-3,022 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 27,523 | 179 | 242,620 | 114,589 | N/A |
| Other Financing Activity | 0 | -1,163 | 0 | 0 | 0 |
| Financing Cash Flow | $27,523 | $-984 | $242,620 | $114,589 | $N/A |
| Exchange Rate Effect | -12,442 | 302 | 11,738 | -1,014 | N/A |
| Beginning Cash Position | 119,063 | 231,576 | 74,571 | 16,340 | N/A |
| End Cash Position | 48,606 | 119,063 | 231,576 | 74,571 | N/A |
| Net Cash Flow | $-70,457 | $-112,513 | $157,005 | $58,231 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -78,224 | -107,557 | -94,965 | -52,322 | N/A |
| Capital Expenditure | -7,014 | -4,274 | -2,513 | -2,977 | N/A |
| Free Cash Flow | -85,238 | -111,831 | -97,478 | -55,299 | 0 |